CCCC compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

CCCCC4 Therapeutics, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

CCCCC4 Therapeutics, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CCCC2 of 4 reports

0 of 2at or beyond implied

Reportimpliedrealized× implied

Nov 5 '26±16.3%▼−5.45%×0.34

Q2 FY26±20.6%▲+6.91%×0.33

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.7%▲+3.73%×1.00

Q2 FY26±4.1%▲+4.57%×1.12

= impliedCCCC realized, solidAMGN realized, hatchedOne scale, both sides: full bar = 21%× = |realized| ÷ impliedspan: CCCC 86d · AMGN 273dSource: market data

Q1 FY26

±3.9%

▼−4.75%

×1.23

Feb 4 '26±3.7%▲+8.15%×2.22

CCCCC4 Therapeutics, Inc.

2.94▼−5.73%· post 2.94

Mkt cap$387.4MRevenue$8MQ3 FY26Revenue$36MFY25

AMGNAmgen Inc

461.49▼−3.55%· post 460.22

ClosedNov 5 '26

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

ClosedNov 5 '26

CCCCC4 Therapeutics, Inc.

AMGNAmgen Inc

2.94▼−5.73%post 2.94

Price

461.49▼−3.55%post 460.22

$387.4M

Mkt cap

$249.0B

Q3 FY26$8M

Revenue

$10.4BQ3 FY26

FY25$36M

Revenue

$36.8BFY25

CCCC2.94▼−5.73%vsAMGN461.49▼−3.55%ClosedNov 5 '26